60542 Federal Register / Vol. 70, No. 200 / Tuesday, October 18, 2005 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Advisory Committee to the Director, 

National Cancer Institute. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Advisory Committee 

to the Director, National Cancer Institute. 

Date: October 31, 2005. 

Time: 11 a.m. to 11:45 a.m. 

Agenda: The purpose of the meeting will 

be to review the key Sarcoma PRG 

recommendations. 

Place: National Institutes of Health, 

National Cancer Institute, 31 Center Drive, 

Room 11A48, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Cherie Nichols, Director of 

Science Planning and Assessment, National 

Cancer Institute, National Institutes of 

Health, Building 6116, Room 205, Bethesda, 

MD 20892, (301) 496–5515. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

deainfo.nci.nih.gov/advisory/joint/htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: October 4, 2005. 

Anthony M. Coelho, Jr., 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 05–20755 Filed 10–17–05; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Sickle Cell Disease Advisory 

Committee. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Sickle Cell Disease 

Advisory Committee. 

Date: November 7, 2005. 

Time: 8:30 a.m. to 4 p.m. 

Agenda: Discussion of Program policies 

and issues. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Room 9112, Bethesda, MD 

20892. 

Contact Person: Robert B. Moore, PhD, 

Health Scientist Administrator, Blood 

Diseases Program, Division of Blood Disease 

and Resources, National Heart, Lung, and 

Blood Institute, NIH, 6701 Rockledge Drive, 

Room 10162, Bethesda, MD 20892, 301/435–

0050. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.nhlbi.nih.gov/meetings/index.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS). 

Dated: October 6, 2005. 

Anthony M. Coelho, Jr., 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 05–20730 Filed 10–17–05; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel, 

Review of Research Scientist Development 

Awards (K01s). 

Date: November 3–4, 2005. 

Time: 6 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Hotel, 2033 M Street, 

NW., Washington, DC 20036. 

Contact Person: Zoe Huang, MD, Health 

Scientist Administrator, Review Branch, 

Room 7190, Division of Extramural Affairs, 

National Heaart, Lung, and Blood Institute, 

6701 Rockledge Drive, Room 7190, Bethesda, 

MD 20892–7924, 301–435–0314, 

huangz@nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel, 

Innovative Technologies for Engineering 

Small Blood Vessels. 

Date: November 9, 2005. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sheraton Columbia Hotel, 10207 

Wincopin Circle, Columbia, MD 21044. 

Contact Person: David A. Wilson, PhD, 

Scientific Review Administrator, Division of 

Extramural Affairs, National Heart, Lung, and 

Blood Institute, National Institutes of Health, 

6701 Rockledge Drive, Room 7204, MSC 

7924, Bethesda, MD 20892, 301/435–0929. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel, 

Review of Research Program Project 

Applications (PO1s). 

Date: November 14, 2005. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sheraton Columbia Hotel, 10207 

Wincopin Circle, Columbia, MD 21044. 

Contact Person: Valerie L. Prenger, PhD, 

Scientific Review Administrator, Division of 

Extramural Affairs, National Heart, Lung, and 

Blood Institute, 6701 Rockledge Drive, Room 

7214, Bethesda, MD 20892–7924, (301) 435–

0270. prengerv@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: October 3, 2005. 

Anthony M. Coelho, Jr. 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 05–20751 Filed 10–17–05; 8:45 am] 

BILLING CODE 4140–01–M